Skip to content
preclinicalAnti-Aging

Progeline

Also known as: Trifluoroacetyl Tripeptide-2, Anti-Progerin Peptide, TFA-Tripeptide-2, Progeline by Lucas Meyer Cosmetics

Progeline is a synthetic tripeptide designed to target progerin, a truncated form of the nuclear envelope protein lamin A that accumulates in aging cells and is the causative protein in Hutchinson-Gilford progeria syndrome (premature aging). By inhibiting progerin synthesis and promoting its degradation, Progeline addresses aging at the cellular/nuclear level rather than simply targeting downstream cosmetic symptoms. It also reduces elastin glycation and improves skin firmness by protecting the structural integrity of the nuclear lamina.

3 cited references·5 researched benefits

Quick Answer

Progeline (Trifluoroacetyl Tripeptide-2) is a synthetic peptide that targets progerin, the truncated lamin A protein that accumulates in aging cells and drives cellular senescence. By reducing progerin levels, it addresses skin aging at the nuclear/cellular level. Clinical studies show improvements in skin firmness, jawline definition, and wrinkle depth after 8 weeks. It also inhibits elastin glycation, preserving skin elasticity that degrades with age.

Key Facts

Mechanism
Progeline targets the nuclear lamina — the protein meshwork lining the inner nuclear membrane that provides structural support to the cell nucleus. With age, an aberrant splice variant of lamin A called progerin accumulates in cells. Progerin disrupts nuclear shape, impairs DNA repair, alters gene expression, and drives cellular senescence. In Hutchinson-Gilford progeria syndrome, massive progerin accumulation causes dramatically accelerated aging. Progeline reduces progerin levels through two proposed mechanisms: downregulation of the LMNA gene splice variant that produces progerin, and promotion of progerin protein degradation via autophagy. By reducing nuclear progerin accumulation, the peptide helps maintain normal nuclear morphology, DNA repair capacity, and gene expression patterns in aging cells. Additionally, it inhibits non-enzymatic glycation of elastin fibers, preserving the elastic recoil of skin that is progressively lost with age.
Research Status
preclinical
Half-Life
N/A (topical cosmeceutical — not systemically absorbed)
Molecular Formula
C₁₇H₂₈F₃N₃O₅
Primary Use
Anti-Aging
Table of Contents

Benefits

  • Reduces progerin accumulation in skin cells, targeting aging at the nuclear/cellular levelpreliminary
  • Improves skin firmness and jawline definition — clinical studies show measurable improvement in facial contour after 56 dayspreliminary
  • Inhibits elastin glycation, preserving skin elasticity and preventing stiffening of elastic fiberspreliminary
  • Reduces wrinkle depth and improves overall skin smoothnesspreliminary
  • Addresses a fundamental mechanism of cellular aging rather than only treating cosmetic symptomspreliminary

Dosage Protocols

RouteDosage RangeFrequencyNotes
Topical serum2–3% Progeline solution2x dailyApply to clean skin, particularly targeting areas of skin laxity (jawline, neck, nasolabial folds). The neck and jawline are particularly responsive due to the significant role of elastin loss in sagging in these areas. Allow full absorption before layering other products.
Topical cream (face and neck)2–3% Progeline solution2x daily (morning and evening)Often combined with other anti-aging peptides (Matrixyl, GHK-Cu) for comprehensive multi-mechanism anti-aging. Stable at pH 5.0–7.0. Results typically visible after 4–8 weeks of consistent use.

Medical disclaimer

Dosage information is provided for educational reference only. Always follow your prescriber's instructions and consult a qualified healthcare provider before starting any peptide protocol.

Side Effects

  • Mild skin irritation at the application site in sensitive individualsrare
  • No systemic adverse effects reported at cosmetic concentrationsrare
  • Contains trifluoroacetyl group — individuals with fluorine compound sensitivities should patch-test firstrare

Frequently Asked Questions

What is progerin and why does it cause aging?
Progerin is a truncated, dysfunctional form of lamin A, a key structural protein of the nuclear lamina. In Hutchinson-Gilford progeria syndrome, a single point mutation causes massive progerin production, resulting in dramatically accelerated aging (children age and die by their teens). Normal aging also involves gradual progerin accumulation — healthy elderly individuals have measurably higher progerin levels in their cells compared to young people. Progerin distorts nuclear shape, impairs DNA repair, disrupts gene expression, and accelerates cellular senescence.
How does Progeline differ from other anti-aging peptides?
Most anti-aging peptides target downstream cosmetic effects — stimulating collagen (Matrixyl), relaxing muscles (Argireline), or providing antioxidant protection (GHK-Cu). Progeline is unique in targeting a fundamental mechanism of cellular aging at the nuclear level. By reducing progerin accumulation, it addresses the upstream cause of cellular dysfunction rather than just the visible symptoms. This makes it conceptually complementary to collagen-stimulating and antioxidant peptides.
Is there scientific evidence that topical progerin reduction works?
The connection between progerin and aging is well-established in cell biology and genetics. However, the evidence that topical Progeline peptide effectively reduces progerin levels in human skin in vivo is limited primarily to manufacturer-sponsored studies. Independent peer-reviewed clinical trials are still needed. The peptide concept is scientifically sound, but consumers should maintain realistic expectations until more robust clinical data is available.

References

  1. 1
    Progerin and aging: when cellular architecture goes awry(2010)PubMed ↗
  2. 2
    Progeline: a peptide approach to anti-aging targeting the nuclear lamina and progerin accumulation(2013)
  3. 3
    Nuclear lamins in aging: from molecular mechanisms to potential cosmeceutical interventions(2019)

Latest Research

Last updated: 2026-02-19